Skip to content

Evaluation of an Investigational Blood Glucose Monitoring System

Performance of the Ninja 3 Blood Glucose Monitoring System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01859494
Enrollment
219
Registered
2013-05-22
Start date
2013-04-30
Completion date
2013-05-31
Last updated
2017-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study was to determine if untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.

Interventions

DEVICENINJA 3 Investigational Blood Glucose Monitoring System

Untrained subjects with diabetes self-tested capillary fingerstick and palm blood using the NINJA 3 Investigational Blood Glucose Monitoring System. Study staff tested subject fingerstick blood. All BG results were compared to reference method results obtained from subject capillary plasma.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Males and females, 18 years of age and older 2. People with type 1 or type 2 diabetes 3. Able to speak, read, and understand English 4. Willing to complete all study procedures

Exclusion criteria

1. Hemophilia or any other bleeding disorder 2. Pregnancy 3. Physical, visual, or neurological impairments that would make the person unable to perform testing with the BGM 4. Previously participated in a BG monitor study using the Ninja 3 BGMS 5. Working for a medical laboratory, hospital, or other clinical setting that involves training on and clinical use of blood glucose monitors 6. Working for a competitive medical device company, or having an immediate family member who works for such a company 7. A condition which, in the opinion of the investigator or designee, would put the person or study conduct at risk. The enrollment criteria for the study population: 1. At least 60% of subjects will be younger than age 65 2. At least 20% of subjects will have type 1 diabetes 3. At least 50% of subjects with type 2 diabetes wil be insulin users.

Design outcomes

Primary

MeasureTime frameDescription
Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL (<75mg/dL) or Within +/-20% (>=75mg/dL) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results were used to calculate the number of BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma).

Secondary

MeasureTime frameDescription
Number of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 15mg/dL (<100mg/L YSI) or Within +/- 15% (>=100mg/dL YSI) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI BG results were used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma)
Number of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 12.5mg/dL (<100mg/L YSI) or Within +/- 12.5% (>=100mg/dL YSI) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI BG results were used to calculate the number of BGMS results within +/- 12.5mg/dL (\<100mg/dL YSI capillary plasma) or +/- 12.5% (\>=100mg/dL YSI capillary plasma)
Number of Glucose Results From Alternative Site Testing (AST) of the Palm Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method1 hourUntrained subjects with diabetes self-tested Alternative Site (AST) palm blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS AST results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results were used to calculate the number of AST BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma)
Number of Subject Fingerstick BG Results Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method When Tested by Study Staff1 hourStudy staff tested subject fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma results were used to calculate the number of BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma)
Number of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire Statements1 hourStaff obtained subject responses using short questionnaires to provide feedback on instructions for use and the basic operation of the BGMS. Subjects could respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' or 'Strongly Disagree'.

Countries

United States

Participant flow

Participants by arm

ArmCount
Users of the Monitoring System
Untrained subjects with diabetes used the NINJA 3 Investigational Blood Glucose Monitoring System. NINJA 3 Investigational Blood Glucose Monitoring System: Untrained subjects with diabetes self-tested capillary fingerstick and palm blood using the NINJA 3 Investigational Blood Glucose Monitoring System. Study staff tested subject fingerstick blood. All BG results were compared to reference method results obtained from subject capillary plasma.
221
Total221

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1

Baseline characteristics

CharacteristicUsers of the Monitoring System
Age, Continuous51.8 years
Ethnicity (NIH/OMB)
Hispanic or Latino
22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
197 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Gender
Female
108 Participants
Gender
Male
113 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
4 participants
Race/Ethnicity, Customized
Asian
9 participants
Race/Ethnicity, Customized
Black or African American
10 participants
Race/Ethnicity, Customized
More than one race
3 participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
2 participants
Race/Ethnicity, Customized
Unknown or Not Reported
5 participants
Race/Ethnicity, Customized
White
194 participants
Region of Enrollment
United States
221 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
8 / 219
serious
Total, serious adverse events
0 / 219

Outcome results

Primary

Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL (<75mg/dL) or Within +/-20% (>=75mg/dL) of Laboratory Glucose Method

Untrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results were used to calculate the number of BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma).

Time frame: 1 hour

Population: 218 (219-1) Blood glucose results were analyzed. One subject discontinued from testing after low Blood Glucose (BG) fingerstick result (hypoglycemia AE), thus no reference result available for that subject.

ArmMeasureValue (NUMBER)
Users of the Monitoring SystemNumber of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL (<75mg/dL) or Within +/-20% (>=75mg/dL) of Laboratory Glucose Method218 Blood Glucose results within 15mg/dL/20%
Secondary

Number of Glucose Results From Alternative Site Testing (AST) of the Palm Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method

Untrained subjects with diabetes self-tested Alternative Site (AST) palm blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS AST results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results were used to calculate the number of AST BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma)

Time frame: 1 hour

Population: 211 (219-8) Blood glucose results were analyzed. One subject discontinued from all testing after hypoglycemia Adverse Event. Three subjects with low blood sugar did not attempt palm testing per protocol. Two subjects had low blood sugar; their palm results were not evaluable per protocol. Two subjects failed to obtain palm blood for testing.

ArmMeasureValue (NUMBER)
Users of the Monitoring SystemNumber of Glucose Results From Alternative Site Testing (AST) of the Palm Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method209 Blood Glucose results within 15mg/dL/20%
Secondary

Number of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 12.5mg/dL (<100mg/L YSI) or Within +/- 12.5% (>=100mg/dL YSI) of Laboratory Glucose Method

Untrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI BG results were used to calculate the number of BGMS results within +/- 12.5mg/dL (\<100mg/dL YSI capillary plasma) or +/- 12.5% (\>=100mg/dL YSI capillary plasma)

Time frame: 1 hour

Population: 218 (219-1) Blood glucose results were analyzed. One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE), thus no reference result available for that subject.

ArmMeasureValue (NUMBER)
Users of the Monitoring SystemNumber of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 12.5mg/dL (<100mg/L YSI) or Within +/- 12.5% (>=100mg/dL YSI) of Laboratory Glucose Method214 Bld Glucose results w/in 12.5mg/dL/12.5%
Secondary

Number of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 15mg/dL (<100mg/L YSI) or Within +/- 15% (>=100mg/dL YSI) of Laboratory Glucose Method

Untrained subjects with diabetes self-tested fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with subject capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI BG results were used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma)

Time frame: 1 hour

Population: 218 (219-1) Blood glucose results were analyzed. One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE), thus no reference result available for that subject.

ArmMeasureValue (NUMBER)
Users of the Monitoring SystemNumber of Self-Test Fingerstick Blood Glucose (BG)Results Within +/- 15mg/dL (<100mg/L YSI) or Within +/- 15% (>=100mg/dL YSI) of Laboratory Glucose Method215 Blood Glucose results within 15mg/dL/15%
Secondary

Number of Subject Fingerstick BG Results Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method When Tested by Study Staff

Study staff tested subject fingerstick blood using an investigational Blood Glucose Monitoring System (BGMS). BGMS results were compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma results were used to calculate the number of BGMS results within +/- 15mg/dL (\<75mg/dL YSI capillary plasma) or +/- 20% (\>=75mg/dL YSI capillary plasma)

Time frame: 1 hour

Population: 218 (219-1) Blood glucose results were analyzed. One subject discontinued from testing after low BG result (hypoglycemia AE), thus no reference result available for that subject.

ArmMeasureValue (NUMBER)
Users of the Monitoring SystemNumber of Subject Fingerstick BG Results Within +/- 15mg/dL (<75mg/L YSI) or Within +/- 20% (>=75mg/dL YSI) of Laboratory Glucose Method When Tested by Study Staff218 Blood Glucose results within 15mg/dL/20%
Secondary

Number of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire Statements

Staff obtained subject responses using short questionnaires to provide feedback on instructions for use and the basic operation of the BGMS. Subjects could respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' or 'Strongly Disagree'.

Time frame: 1 hour

Population: 218 (219-1) responses were analyzed. One subject discontinued from testing after low BG result (hypoglycemia Adverse Event).

ArmMeasureGroupValue (NUMBER)
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsI find it easy to do a blood test with this meter.218 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsThe meter display was easy to see and read.216 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsIt was easy to understand my test results.218 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsI like the overall meter design.215 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsI find the meter easy to use.217 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsThe instructions were easy to understand.213 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsInstructions clearly explain how to run a test.216 Participant Responses
Users of the Monitoring SystemNumber of Subject Responses That 'Strongly Agree' or 'Agree' or Are 'Neutral' With Questionnaire StatementsInstructions clearly explain meter error messages.217 Participant Responses

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026